LBP and iFABP mismatch in the evaluation of intestinal barrier dysfunction due to SARS-CoV-2 infection
- 1Laboratório de Investigação Médica da Disciplina de Emergências Clínicas, Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo São Paulo, SP, Brazil.
- 0Laboratório de Investigação Médica da Disciplina de Emergências Clínicas, Departamento de Clínica Médica, Faculdade de Medicina da Universidade de São Paulo São Paulo, SP, Brazil.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.COVID-19 intestinal damage stems from SARS-CoV-2 affecting tight junctions, particularly in older adults. Biomarkers like LPS-Binding Protein and ileal Fatty Acid-Binding Protein indicate barrier dysfunction and aid in patient discrimination.
Area Of Science
- Gastroenterology
- Infectious Diseases
- Immunology
Background
- SARS-CoV-2 infection can trigger systemic inflammatory response syndrome and extrapulmonary complications.
- Intestinal damage in COVID-19 patients is investigated for direct viral action on epithelial cells, focusing on tight junctions.
Purpose Of The Study
- To determine if COVID-19 causes intestinal damage via direct viral effects on intestinal epithelial cells, specifically targeting tight junctions.
- To analyze plasma markers (LPS-Binding Protein and ileal Fatty Acid-Binding Protein) and cytokine levels in relation to bacterial co-infection and age in severe SARS-CoV-2 patients.
Main Methods
- Retrospective observational study involving 87 patients with severe SARS-CoV-2 infection.
- Measurement of plasma LPS-Binding Protein (LBP) and ileal Fatty Acid-Binding Protein (iFABP) levels.
- Evaluation of tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) in relation to co-infections and age groups.
Main Results
- Higher TNF-α and IL-1β levels were observed in patients with bacterial co-infection; TNF-α was also elevated in older patients.
- Plasma LBP levels were higher in bacterially co-infected patients but not significantly different between age groups.
- Plasma iFABP levels were higher in the older population, suggesting increased intestinal epithelial damage in this group.
Conclusions
- SARS-CoV-2-induced intestinal barrier dysfunction primarily involves damage to the intestinal tight junction complex, with less impact on enterocytes.
- Elevated LBP, iFABP, and cytokine levels can differentiate between bacterially infected patients and identify elderly patients with increased intestinal epithelial damage.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:30
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
IBS-C is primarily characterized by constipation. Individuals may experience infrequent bowel movements, difficulty passing stools, or a sensation of incomplete evacuation.
IBS-D, which involves recurrent episodes of diarrhea, is marked by an urgency to...

